News

Psychosocial factors have profound effects on the way people live with diabetes, but how can we apply findings from behavioural research to diabetes care? Two insightful, eye-opening presentations at the 202...

Do recent studies showing unprecedented success for weight loss-inducing medications spell an end for surgical interventions to treat obesity and type 2 diabetes? Far from it, say Professor Carel Le Roux and...

Semaglutide shows promise as an obesity treatment yet again, but this time in people with type 2 diabetes

Nearly all ulcers are preventable, which is why foot care and education is such a vital part of looking after diabetes patients – and took centre stage at one of the sessions of this year’s Diabetes UK Profe...

Continuing the EASD e-Learning Insulin@100 series, Professor Eelco de Koning turns to the subject of physiological insulin replacement by transplantation.

Fasting-induced stimulation of SIRT1 holds the key to an association between fasting regimens and the prevention of microvascular complications in diabetes, according to a new study in Diabetologia.

This year marks the second Ramadan carried out under the shadow of the COVID-19 pandemic. It is an event that already comes with additional layers of risk for Muslims with diabetes, as Dr Sarah Ali, consulta...

Awareness among healthcare professionals and the importance of education and discussion with patients were key points in a survey of issues around hypoglycaemia and how to fast safely during Ramadan at the S...

In a lively and thought-provoking contribution to our Insulin@100 series, Professor Tina Vilsbøll takes us on a whistlestop tour of insulin’s clinical use – past, present and future.

Study shows machine-learning-based clustering using finite mixture models can help identify phenogroups of people with type 2 diabetes, distinct clinical characteristics and cardiovascular risk.

Primary care is an ideal place to identify hypoglycaemia and help patients to avoid it in the future, according to the latest Primary Care Diabetes Europe (PCDE) webinar

Sometimes seen as the price you pay for good glycaemic control, hypoglycaemia can have a profoundly damaging impact on the lives and wellbeing of many people on insulin and other glucose-lowering therapies. 

Severe hyperglycaemia shortly after admission to a non-ICU hospital setting in patients with COVID-19 is associated with a 7-fold increase in mortality risk, according to a study published in Diabetes Care. 

Promising results from the Pre-POInT-early study, which investigated the safety and immune effects of high-dose oral insulin immunotherapy in children before the age of 2, when they are most susceptible to d...

The latest feature in our series celebrating Insulin@100 focuses on the potent but precarious synergy of exercise and insulin.

Transplantation conference hears calls for an end to the notion of islet transplantation as experimental therapy, to be dealt with separately from whole pancreas transplantation in national allocation polici...

In lock step with the pandemics of obesity and type 2 diabetes, another, less talked about condition is on the rise: non-alcoholic fatty liver disease (NAFLD).

Links between non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes loomed large at the Paris Hepatology Conference in March, as did the potential use of diabetes treatments to counter the rise of th...

EASD e-Learning’s latest initiative, ‘The long and the short it’, launches today.

Are DCD donors the solution to boosting islet transplantations?

Results from the Coronavirus SARS-CoV-2 and Diabetes Outcomes (CORONADO) study have identified variables linked to hospital discharge or to death among patients with diabetes hospitalised for COVID-19, estab...